This study tests a cream called tapinarof in 58 children aged 2 to 17 with plaque psoriasis. The goal is to see if the cream is safe and how it affects skin irritation. Children apply the cream daily, and doctors monitor for side effects and skin reactions.
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Disease control
Last updated May 07, 2026 18:42 UTC